One-year mortality of hematopoietic stem cell recipients admitted to an intensive care unit in a dedicated Brazilian cancer center: a retrospective cohort study.
Leticia Vicentin Finencio ArchanjoPedro CarusoAntonio Paulo Nassar JuniorPublished in: Sao Paulo medical journal = Revista paulista de medicina (2022)
Allogeneic HSCT recipients admitted to the ICU had higher short- and long-term mortality rates than autologous HSCT recipients, even after adjusting for age and severity at ICU admission.